Reframe Daily: Your EXCLUSIVE EARLY Access to *Personalized* Health News + The Usual :)

Reframe Daily is where Christin Chong (neuroscience PhD, chaplain, healthtech strategy consultant) curates optimistic and credible healthtech news so you don’t have to.

Christin’s note: THANK YOU for your support of Reframe Daily!

You are welcomed to the next iteration where you can receive personalized healthcare news in the Reframe discord community! If you enjoyed receiving these news articles and wish for ones more tailored to your specific interests, now’s the time…

For exclusive early access, please fill out this quick 2 question form here and you’ll get the discord URL right away: https://forms.gle/tN3oabFTsDF21VnS8

(I know, I know—why do I need your email if I am literally sending you an email?! The reason why is b/c Discord doesn’t actually give me access to your email and it is a bit challenging to associate your discord username with your email address ^_^;;)

And now onto today’s Good News…

Today in one sentence: A new once-a-day pill tames hard-to-treat high blood pressure; easy bladder-training beats medicine for over-active bladders; fast micro-ultrasound spots prostate cancer as well as pricey MRI; everyday metformin helps people bounce back from COVID-19 faster; and a four-week online mindfulness class calms stress for patients just home from the hospital.

Good News: Scientists found that a once-a-day pill called baxdrostat safely lowered blood pressure in people whose adrenal glands make too much aldosterone, so they may need fewer clinic visits and injections. 

Phase 2a Study of Baxdrostat in Primary Aldosteronism

Market readiness: 🙂🙂 (promising early Phase 2 data; still needs large Phase 3 trials and FDA review before it reaches pharmacies)

Good News: Simple bladder-training exercises worked just as well as medicine for over-active bladder, meaning many people can ditch pills and side-effects while still avoiding “gotta-go” moments. 

Behavioral Compared With Drug Therapy for Overactive Bladder: A Randomized Trial

Market readiness: 🙂🙂🙂🙂 (clinics can adopt the exercise program right now; guidelines and staff training will speed wider use)

Good News: Using micro-ultrasound to guide prostate biopsies spotted significant cancers just as well as pricey MRI gear—but the scan is faster and cheaper, so more men can get accurate checks sooner. 

Microultrasonography-Guided vs MRI-Guided Biopsy for Prostate Cancer Diagnosis—The OPTIMUM Randomized Clinical Trial

Market readiness: 🙂🙂🙂🙂 (micro-ultrasound machines already have FDA clearance; clinics simply need to add the protocol and train staff)

Good News: The everyday diabetes drug metformin helped adults with COVID-19 recover faster and stay better, offering an inexpensive add-on that doctors can prescribe right away. 

Metformin and Time to Sustained Recovery in Adults With COVID-19 (ACTIV-6 Trial)

Market readiness: 🙂🙂🙂🙂🙂 (metformin is already FDA-approved and on pharmacy shelves; clinicians can use it off-label while regulators consider label expansion)

Good News: A four-week online mindfulness course cut stress, worry, and sadness in people who had just left the hospital after COVID-19—no pills needed. 

Effectiveness of an Online Mindfulness-Based Stress Reduction Intervention on Psychological Distress After COVID-19 Hospital Discharge

Market readiness: 🙂🙂🙂🙂 (mindfulness apps and tele-health classes are already available; larger U.S. studies will strengthen the case, but the program can roll out now)

That’s all folks, thank you for taking the time to reframe.